{"id":106874,"date":"2025-05-16T17:51:11","date_gmt":"2025-05-16T17:51:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/106874\/"},"modified":"2025-05-16T17:51:11","modified_gmt":"2025-05-16T17:51:11","slug":"how-new-weight-loss-drugs-work-and-their-downsides","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/106874\/","title":{"rendered":"How new weight loss drugs work &#8211; and their downsides"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/05\/4K7EXJ4_David_Kessler_2_jpg\" width=\"1050\" height=\"616\" alt=\"Former FDA Commissioner Dr. David A. Kessler on his new book Diet, Drugs And Dopamine: he says the new class of &#10;weight loss drugs have provided a genuine breakthrough - but there are also downsides.\"\/><\/p>\n<p class=\"photo-captioned__information\">\n<p>Photo: supplied\/ Joy Asico-Smith\n<\/p>\n<p>Dr. David A. Kessler is a former Commissioner of the American Food and Drug Administration.<\/p>\n<p>He&#8217;s written extensively on the food industry&#8217;s role in engineering addictive foods, which contributes to the obesity epidemic globally. Dr Kessler has also struggled with yo-yo&#8217;ing weight and his new book &#8220;Diet, Drugs And Dopamine&#8221; looks at the the new class of weight loss drugs. This class of drugs, called GLP-1 which increase feelings of satisfaction or fullness after eating, and help to quiet what he callls &#8220;food noise&#8221;.<\/p>\n<p>Dr Kessler says the drugs represent a genuine breakthrough- but he says they also come with downsides, and no progress will be made until we understand the addictive nature of certain foods.<\/p>\n","protected":false},"excerpt":{"rendered":"Photo: supplied\/ Joy Asico-Smith Dr. David A. Kessler is a former Commissioner of the American Food and Drug&hellip;\n","protected":false},"author":2,"featured_media":106875,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[1816,9409,105,4326,12,196,10975,10973,10974,16,15],"class_list":{"0":"post-106874","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-audio","9":"tag-current-affairs","10":"tag-health","11":"tag-medication","12":"tag-news","13":"tag-podcasts","14":"tag-public-radio","15":"tag-radio-new-zealand","16":"tag-rnz","17":"tag-uk","18":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114518785024581725","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/106874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=106874"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/106874\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/106875"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=106874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=106874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=106874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}